Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: Development of a potent and CNS penetrant [3.1.0]-based lead
作者:Carrie K. Jones、Douglas J. Sheffler、Richard Williams、Sataya B. Jadhav、Andrew S. Felts、Ryan D. Morrison、Colleen M. Niswender、J. Scott Daniels、P. Jeffrey Conn、Craig W. Lindsley
DOI:10.1016/j.bmcl.2014.01.013
日期:2014.2
This Letter describes the development and SAR of a novel series of GlyT1 inhibitors derived from a scaffold hopping approach that provided a robust intellectual property position, in lieu of a traditional, expensive HTS campaign. Members within this new [3.1.0]-based series displayed excellent GlyT1 potency, selectivity, free fraction, CNS penetration and efficacy in a preclinical model of schizophrenia (prepulse inhibition). (C) 2014 Elsevier Ltd. All rights reserved.